Results 141 to 150 of about 60,384 (208)

Modulating IDO1 and TDO Inhibition Through Structural Modification of Diaryl Hydroxylamines

open access: yesChemMedChem, Volume 21, Issue 7, 14 April 2026.
Diaryl hydroxylamines have emerged as promising scaffolds for targeting the tryptophan‐catabolizing enzymes indoleamine 2,3‐dioxygenase 1 (IDO1) and tryptophan 2,3‐dioxygenase (TDO), key drivers of tumor immune escape. Building on the reported dual IDO1/TDO inhibitory activity of O‐((3,5‐difluorophenyl)(phenyl)methyl)hydroxylamine, a series of diaryl ...
Angeliki S. Foscolos   +8 more
wiley   +1 more source

Whole-Body Knockout of the AhR (Aryl Hydrocarbon Receptor) Ameliorates Atherosclerosis Due to Altered Lipid Metabolism-Brief Report. [PDF]

open access: yesArterioscler Thromb Vasc Biol
Huchzermeier R   +14 more
europepmc   +1 more source

Back to the Electrofuture: Named Reactions Powered by Electroorganic Syntheses

open access: yesChemSusChem, Volume 19, Issue 7, 14 April 2026.
Bridging classical named reactions with modern electroorganic chemistry, this review presents how electrochemical strategies can revive and reinterpret historically significant transformations, highlighting their emerging potential as sustainable alternatives in contemporary organic synthesis.
Debajit Maiti   +4 more
wiley   +1 more source

The aryl hydrocarbon receptor (AHR) drives human leukocyte antigen (HLA)-II expression in human melanoma. [PDF]

open access: yesJ Exp Clin Cancer Res
Jin Y   +8 more
europepmc   +1 more source

Tryptophan Indole Metabolites Reduce Anastomotic Leakage Through Aryl Hydrocarbon Receptor-Driven Interleukin-22 Production. [PDF]

open access: yesCell Mol Gastroenterol Hepatol
Bantavi V   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy